Popoli et al27 think that the selective A2AR antagonist CSC has a neuroprotective effect during the first 15 minutes after cerebral ischemia in rats, but this effect will disappear after 2 weeks of continuous treatment with the same dose of CSC. Here, ADORA2A is linked to brain ischemia.